News Biohaven Ltd.

Equities

BHVN

VGG1110E1079

End-of-day quote Nyse Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
35.69 ^USD	-13.71%		-10.55%	-16.61%

05:37pm	Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates	MT
Apr. 25	Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates	11:37am	MT
Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	Apr. 25	MT
Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	Apr. 23	MT
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	Apr. 23	MT
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	Apr. 23	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	Apr. 18	MT
Biohaven Prices $230 Million Public Share Offering	Apr. 18	MT
Biohaven Launches $200 Million Common Stock Offering	Apr. 17	MT
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	Feb. 29	MT
Biohaven Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Biohaven Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Biohaven Insider Sold Shares Worth $459,663, According to a Recent SEC Filing	Jan. 02	MT
Certain Common Shares of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 17-NOV-2023.	Nov. 16	CI
Certain Stock Options of Biohaven Ltd. are subject to a Lock-Up Agreement Ending on 17-NOV-2023.	Nov. 16	CI
North American Morning Briefing : Stocks Seen -2-	Nov. 15	DJ
Biohaven Pharmaceutical Q3 Net Loss Narrows	Nov. 14	MT
Biohaven Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Biohaven Pharmaceutical Says Obesity Treatment Candidate Reduces Fat, Improves Lean Mass	23-10-16	MT
Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek®	23-10-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Biohaven Ltd.

Equities

BHVN

VGG1110E1079

Summary

Filters